Product-level innovation boosts gastrointestinal stent adoption

Asia Pacific is estimated to register the highest CAGR through 2031.

The gastrointestinal stent market is projected to reach $820m by 2031, at a compound annual growth rate of 5.7%, according to a MarketsandMarkets report.

One major growth source in the market is product-level innovation, along with the increasing demand for minimally invasive treatment options for gastrointestinal disorders.

By product, the metal stents segment accounted for the largest market share in 2025 due to its better mechanical strength, greater radial force, and longer patency.

By end user, the hospital and clinics segment dominated the market, with a share of 84.4%.

The Asia Pacific gastrointestinal stent market is estimated to register the highest CAGR of 6.4% during the forecast period.